Quantinno Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Quantinno Capital Management's REGN Position: Q3 2026 in Review
Quantinno Capital Management increased its Regeneron Pharmaceuticals (REGN) stake by 44% in Q3 2026, buying an estimated $15.6M and bringing the position to 67,655 shares worth $51.3M. The position accounts for 0.05% of the portfolio, ranked #473.
Quantinno Capital Management first reported a position in REGN in Q1 2022 and has held it in 19 quarters since. 1,427 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Quantinno Capital Management held 67,655 shares of Regeneron Pharmaceuticals worth $51.3M as of Q3 2026.
- Quantinno Capital Management bought 20,646 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $15.6M.
- Regeneron Pharmaceuticals made up 0.05% of Quantinno Capital Management's portfolio in Q3 2026, its #473 holding.
- Quantinno Capital Management first reported a position in Regeneron Pharmaceuticals in Q1 2022 and has held it in 19 quarters since.
- 1,427 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.